TY - JOUR T1 - Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19 related pneumonia JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02130-2020 SP - 2002130 AU - Cosimo Franco AU - Nicola Facciolongo AU - Roberto Tonelli AU - Roberto Dongilli AU - Andrea Vianello AU - Lara Pisani AU - Raffaele Scala AU - Mario Malerba AU - Annalisa Carlucci AU - Emanuele Alberto Negri AU - Greta Spoladore AU - Giovanna Arcaro AU - Paolo Amedeo Tillio AU - Cinzia Lastoria AU - Gioachino Schifino AU - Luca Tabbi’ AU - Luca Guidelli AU - Giovanni Guaraldi AU - V. Marco Ranieri AU - Enrico Clini AU - Stefano Nava Y1 - 2020/01/01 UR - http://erj.ersjournals.com/content/early/2020/07/30/13993003.02130-2020.abstract N2 - Introduction The Coronavirus 2(SARS-CoV-2) outbreak spread rapidly in Italy and the lack of intensive care unit(ICU) beds soon became evident, forcing the application of noninvasive respiratory support(NRS) outside the ICU, raising concerns over staff contamination. We aimed to analyse the safety of the hospital staff, the feasibility, and outcomes of NRS applied to patients outside the ICU.Methods In this observational study, data from 670 consecutive patients with confirmed COVID-19 referred to the Pulmonology Units in nine hospitals between March 1st and May 10th,2020 were analysed. Data were collected including medication, mode and usage of the NRS (i.e. high-flow nasal cannula (HFNC), continuous positive airway pressure (CPAP), noninvasive ventilation(NIV)), length of stay in hospital, endotracheal intubation(ETI) and deaths.Results Forty-two health-care workers (11.4%) tested positive for infection, but only three of them required hospitalisation. Data are reported for all patients (69.3% male), whose mean age was 68 (sd 13) years. The PaO2/FiO2 ratio at baseline was 152±79, and the majority of patients (49.3%) were treated with CPAP. The overall unadjusted 30-day mortality rate was 26.9% with 16%, 30%, and 30%, while the total ETI rate was 27% with 29%, 25% and 28%, for HFNC, CPAP, and NIV, respectively, and the relative probability to die was not related to the NRS used after adjustment for confounders. ETI and length of stay were not different among the groups. Mortality rate increased with age and comorbidity class progression.Conclusions The application of NRS outside the ICU is feasible and associated with favourable outcomes. Nonetheless, it was associated with a risk of staff contamination.In patients with Coronavirus 2 infection and Acute Respiratory Failure, we demonstrated that the utilization of noninvasive respiratory support delivered outside the ICU, was feasible and effective, but associated with a risk of staff contamination ER -